Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 22.72
+1.16 (5.38%)
Aug 7, 2026, 4:10 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 2.88 billion as of August 7, 2026. Its market cap has increased by 34.40% in one year.
Market Cap
2.88B
Enterprise Value
2.58B
Revenue
64.65M
Ranking
n/a
PE Ratio
97.64
Stock Price
22.72
ChartMarket Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 2.88B, an increase of 13,663.87%. That is a compound annual growth rate of 25.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 2.88B | 22.21% |
| Dec 31, 2025 | 2.36B | 48.44% |
| Dec 31, 2024 | 1.59B | -50.04% |
| Dec 29, 2023 | 3.18B | 217.33% |
| Dec 30, 2022 | 1.00B | 110.88% |
| Dec 31, 2021 | 474.89M | 222.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.90B |
| Mesoblast | 2.77B |
| PYC Therapeutics | 1.96B |
| Clarity Pharmaceuticals | 1.01B |
| Clinuvel Pharmaceuticals | 457.38M |
| Racura Oncology | 402.85M |
| Tetratherix | 395.26M |
| Starpharma Holdings | 315.86M |